Novel circular antimicrobial peptides to combat a critical listed bacterial pathogen Multi drug resistant Acinetobacter baumannii.

Acinetobacter baumannii, acritical nosocomial pathogen, is one of the leading causes of human mortality, globally. The extraordinary genetic plasticity of A. baumannii leads to a high propensity antimicrobial resistance trait that demands urgent attention for alternative therapeutics.